← Back to Search

Iron Supplement

IV Iron Therapy for Anemia After Broken Bones

Phase 4
Recruiting
Led By Zachary M Working, MD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients age 18-89 admitted with a lower extremity or pelvis fracture requiring surgical stabilization
Acute blood loss anemia as defined by hemoglobin concentration between 7.0-11.0g/dL within seven days post-operatively from definitive fracture stabilization during the hospital admission
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is testing whether giving iron intravenously to people with orthopedic injuries can help them recover better by reducing anemia, fatigue, and depression.

Who is the study for?
This trial is for adults aged 18-89 with anemia due to blood loss from a lower extremity or pelvis fracture requiring surgery. Participants must have hemoglobin levels between 7.0-11.0g/dL post-surgery and cannot be on certain medications, have specific pre-existing conditions, be pregnant, or belong to the Jehovah's Witness faith.Check my eligibility
What is being tested?
The study tests if a single dose of intravenous iron (InFed) can help people recover their normal hemoglobin levels faster after orthopaedic trauma compared to a saline placebo. It also looks at how this treatment affects fatigue, physical function, depression, and immune cells.See study design
What are the potential side effects?
Potential side effects of InFed may include allergic reactions like itching or rash, muscle cramps, dizziness, back pain, joint pain; in rare cases severe reactions such as difficulty breathing could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 89 years old with a leg or pelvis fracture needing surgery.
Select...
I have low blood levels due to recent surgery for a broken bone.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluation of protocol adherence
Fatigue
Rate of participant enrollment and screen failures
Secondary outcome measures
Evaluation of ferritin level in response to IVIT after trauma
Evaluation of participant body iron stores in response to IVIT after trauma
Patient Reported Outcome Scores - Depression
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TreatmentExperimental Treatment1 Intervention
Single infusion of low molecular weight Iron Dextran
Group II: PlaceboPlacebo Group1 Intervention
Single infusion of normal saline

Find a Location

Who is running the clinical trial?

Collins Medical TrustOTHER
4 Previous Clinical Trials
115 Total Patients Enrolled
Medical Research FoundationUNKNOWN
Oregon Health and Science UniversityLead Sponsor
979 Previous Clinical Trials
7,386,311 Total Patients Enrolled
~50 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top